Ibunoven Zatoki

Pseudoephedrine Hydrochloride/Ibuprofen, the active ingredient in Ibunoven Zatoki, is a combined decongestant and non‑steroidal anti‑inflammatory drug presented as an oral formulation for systemic use. It relieves nasal congestion by narrowing blood vessels in the nasal mucosa and reduces pain, fever, and inflammation through inhibition of prostaglandin synthesis. The product is intended for use in adults and children as directed by a qualified healthcare professional.

GNH USA supplies Ibunoven Zatoki as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ibunoven Zatoki combines a decongestant and an NSAID, addressing conditions of the upper respiratory tract and mild to moderate pain.

Nasal congestion: provides rapid decongestion to ease breathing during colds or sinusitis. Headache: alleviates tension‑type or mild migraine pain. Fever: lowers elevated body temperature in acute febrile episodes. Musculoskeletal pain: reduces discomfort from strains, sprains or minor arthritis.

The combination may cause a range of adverse reactions, varying in frequency and severity.

Common Side Effects: - Nervousness or restlessness - Insomnia or difficulty sleeping - Nausea or dyspepsia - Mild headache

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis, angioedema) - Elevated blood pressure or cardiac arrhythmia - Gastrointestinal bleeding or ulcer formation - Acute kidney injury or impairment

Prior to prescribing Ibunoven Zatoki, consider the following safety measures.

Pregnancy: use only if clearly needed and after medical advice. Cardiovascular disease: avoid in uncontrolled hypertension or severe heart disease. Renal or hepatic impairment: dose adjustment or caution may be required. Concomitant medications: review for potential interactions, especially anticoagulants and MAO inhibitors. Age restrictions: not recommended for children under the age specified by local regulations. Store at ambient temperature below 25°C: keep in the original pack, protect from moisture.

Ibunoven Zatoki can interact with several drug classes; interactions are categorized by clinical significance.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - Other sympathomimetics: increased cardiovascular stimulation. - Anticoagulants (e.g., warfarin): ibuprofen may enhance bleeding risk. - Selective serotonin reuptake inhibitors (SSRIs): potential for increased bleeding.

Moderate Interactions (Monitor Closely): - Diuretics: may reduce pseudoephedrine efficacy. - ACE inhibitors or ARBs: possible reduction in antihypertensive effect. - Lithium: pseudoephedrine may increase lithium serum levels.